(28 days)
The Spacelabs Healthcare Xprezzon Bedside Monitor passively displays data generated by Spacelabs parameter modules, Flexport interfaces, and other Spacelabs SDLC based products as waveform and numeric displays, trends and alarms. Key monitored parameters available on the model 91393, when employing the Spacelabs Command Module, consist of ECG, respiration, invasive and noninvasive blood pressure, Sp02, temperature and cardiac output. Additional parameters and interfaces to other systems are also available depending on the parameter modules employed.
The Spacelabs Healthcare Xprezzon Bedside Monitor is intended to alert the user to alarm conditions that are reported by Spacelabs Healthcare parameter modules and/or other devices via Flexport interfaces. The patient monitors are also capable of displaying alarm conditions on other monitors that are on the network through the Alarm Watch feature.
The Spacelabs Healthcare Xprezzon Bedside Monitor may also function as a generic display or computer terminal. As a generic display or terminal, the patient monitor allows network based applications to open windows and display information the Xprezzon and other networked monitors.
The Spacelabs Healthcare Xprezzon Bedside Monitor is designed to communicate with a variety of external devices such as displays, network devices, serial devices, user input devices, audio systems, and local/remote recorders.
The Xprezzon Bedside Monitors is intended.for use under the direct supervision of a licensed healthcare practitioner, or by personnel trained in proper use of the equipment in a hospital environment.
The Spacelabs Healthcare Xprezzon Bedside Monitor, Model 91393, is a component of the Spacelabs Healthcare Patient Monitoring System. The Xprezzon Bedside Monitor accepts inputs from the family of Spacelabs Parameter Modules. The monitor accept and displays parameter information, waveform and numeric data, and alarm conditions including arrhythmia information received from the same family of modules.
The Xprezzon Bedside monitor, model 91393, is configured at installation to operate independent of or connected to the Spacelabs Patient monitoring Network. As an independent bedside monitor the device operates from AC and. presents waveform, numeric data, and alarm conditions, including arrhythmia information, received from parameter modules. When physically networked these monitors are able to share their information with a central station or with other monitors on the network according to conditions establish by the user/system administrator. They are also able to connect, via the healthcare institution's network, through Dynamic Network Access (DNA) to other applications available on the network.
Here's an analysis of the provided 510(k) summary regarding the Spacelabs Healthcare Xprezzon Bedside Monitor, focusing on acceptance criteria and supporting studies.
Important Note: The provided 510(k) summary focuses heavily on demonstrating substantial equivalence to a predicate device and does not detail specific, quantitative clinical performance metrics or studies in the way a typical AI/software as a medical device (SaMD) submission would. The "acceptance criteria" discussed below are inferred from the document's claims of functional equivalence and compliance with standards, rather than explicitly stated performance targets for a novel algorithm.
Acceptance Criteria and Reported Device Performance
This 510(k) summary does not present a table of quantitative acceptance criteria with corresponding performance metrics like sensitivity, specificity, or accuracy. Instead, it asserts that the device meets acceptance criteria through validation that supports compliance with standards and verifies accurate data presentation, intended clinical workflows, and user needs, based on functional equivalence to a predicate device.
Given the nature of the device (a bedside monitor displaying data from other modules), the "acceptance criteria" are implicitly tied to the proper functioning of the display and interface, and its ability to accurately present information and alarms generated by external parameter modules.
| Acceptance Criteria (Inferred from document) | Reported Device Performance (Summary Statements) |
|---|---|
| Accurate Presentation of Parameter Data: The monitor should accurately receive and display waveform, numeric data, trends, and alarm conditions generated by Spacelabs parameter modules and Flexport interfaces. | "Test programs verified that parameter data provided by parameter modules... to the Xprezzon Monitor could be accurately presented..." |
| Support for Intended Clinical Workflows: The interface and functionality should support the intended clinical use cases. | "...and that the interface supported the intended clinica! work flows..." |
| Meeting User's Clinical Needs: The device must fulfill the clinical needs of the user (healthcare practitioners). | "...and met the user's clinical needs." |
| Compliance with Relevant Standards: The software and device as a whole should comply with recognized medical device standards. | "...support the compliance of the software to the Standards mentioned in the Software section of this submission." |
| Functional Equivalence to Predicate Device: The device must demonstrate substantial equivalence in core monitoring capabilities to the predicate device. | "The Spacelabs Healthcare Xprezzon Bedside Monitor, Model 91393, is substantially equivalent in design concepts, technologies and materials to the predicate cleared under K102422." |
| Alarm Triage and Display: Ability to alert the user to alarm conditions reported by parameter modules and other devices, including displaying alarms on networked monitors (Alarm Watch). | "The Spacelabs Healthcare Xprezzon Bedside Monitor is intended to alert the user to alarm conditions that are reported by Spacelabs Healthcare parameter modules and/or other devices via Flexport interfaces. ...also capable of displaying alarm conditions on other monitors that are on the network through the Alarm Watch feature." |
Study Details
The provided document describes the validation of the device, but it is not a clinical study in the typical sense of evaluating the performance of a diagnostic or predictive algorithm against ground truth with specific metrics (e.g., sensitivity, specificity). Instead, it is a device validation focused on engineering and software verification.
-
Sample size used for the test set and the data provenance:
- The document does not specify a "test set" in terms of patient data or clinical cases. The validation appears to be primarily laboratory-based and functional testing of the monitor's ability to display data.
- Given the nature of the device (a display monitor), data provenance from specific countries or retrospective/prospective collection is not applicable in the context of this summary.
-
Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- This information is not provided and is likely not relevant as "ground truth" for clinical performance metrics (like those for an arrhythmia detection algorithm) is not part of this specific 510(k) for the bedside monitor itself. The monitor displays ground truth as provided by separate parameter modules.
- The document mentions "user's clinical needs," implying input from healthcare professionals, but specific details on their number or qualifications for establishing ground truth are absent.
-
Adjudication method (e.g., 2+1, 3+1, none) for the test set:
- This is not applicable/not provided. The validation described is not a clinical adjudication study for diagnostic accuracy.
-
If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- No MRMC study was done. This device is a bedside monitor displaying data from other devices, not an AI-powered diagnostic or interpretive tool that assists human readers.
-
If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:
- The "algorithm" here refers to the software controlling the display and networking of the monitor. A "standalone" performance evaluation in the context of a diagnostic algorithm is not applicable. The device's performance is inherently tied to its function as an interface and display. Its "standalone" performance would be its ability to correctly process and display inputs, which was part of the "rigorous testing" mentioned.
-
The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
- The document does not specify a type of ground truth in the context of clinical outcomes or pathology. For a bedside monitor, "ground truth" for validation would likely involve:
- Reference signals/simulations: Using calibrated signal generators to simulate physiological data and ensure the monitor accurately displays it.
- Predicate device comparison: Ensuring the Xprezzon displays data consistent with the predicate device.
- Functional requirements testing: Verifying that different modules integrate correctly and that alarm conditions are triggered and displayed as expected according to predefined functional specifications.
- The document does not specify a type of ground truth in the context of clinical outcomes or pathology. For a bedside monitor, "ground truth" for validation would likely involve:
-
The sample size for the training set:
- This device is not an AI/machine learning model that requires a "training set" of data. Therefore, this information is not applicable/not provided. The software development process mentioned follows standard software engineering practices, not AI model training.
-
How the ground truth for the training set was established:
- As there is no "training set" for an AI model, this question is not applicable.
Summary of the Study:
The "study" described is a developmental and verification/validation engineering process rather than a clinical trial. It involved:
- Rigorous testing to support compliance of software to standards.
- Validation that the software was developed following a robust software development process.
- Test programs to verify:
- Accurate presentation of parameter data from external modules.
- Support for intended clinical workflows.
- Meeting user's clinical needs.
The entire submission hinges on demonstrating substantial equivalence to the predicate device (Spacelabs Medical Ultraview SL Patient Monitors, Model 91387), despite minor hardware and software updates, concluding that the new device is "as safe and effective." No novel claims of diagnostic or predictive accuracy are being made by the monitor itself; it acts as a display and interface for information generated by other cleared devices.
{0}------------------------------------------------
510(k) Premarket Notification Spacelabs Healthcare Xprezzon Bedside Monitor 510(k) Summary
This 510(k) summary of safety and effectiveness information is submitted in accordance with the requirements of SMDA 1990 and 1992.
| Date Prepared: | 29 September 2011 |
|---|---|
| Subject: | 510(k) Summary of Safety and Effectiveness Information for theSpacelabs Healthcare Xprezzon Bedside Monitor |
| Submitter Contact: | Spacelabs Healthcare5150 220th Avenue SEIssaquah, WA 98029Mr. David J. GeraghtySpacelabs HealthcarePhone: +1 (425) 657-7200, ext 5889Fax: +1 (425) 657-7210Email: david.geraghty@spacelabs.com |
| EstablishmentRegistrationNumber: | 3026631 |
| Proprietary Name: | Spacelabs Xprezzon Bedside Monitor, Model 91393 |
| Common Name: | Multiparameter Patient Monitor |
| Classification: | Monitor, Physiological, Patient (with Arrhythmia Detections) |
| Product Code: | Product Code 74 MHX; 21CFR 870.1425. Class II |
| Performance Standard: | The FDA has promulgated the Class II Special ControlsGuidance Document: Arrhythmia Detector and Alarm for thisproduct classification.NOTE: Arrhythmia functionality is implemented in the SpacelabsMedical Multiparameter Module, model 91496, not partof this submission. The model 91496 was cleared underK03142. |
| Predicate Device: | Device Name: Spacelabs Medical Patient Monitors510(k) Number: K102422Manufacturer: Spacelabs Medical, Inc. |
000027
NOV - 2 2011
Spacelabs Healthcare Special 510(k) Xprezzon - 510(k) Summary
29 September 2011 Page 1 of 7
{1}------------------------------------------------
Device Description:
The Spacelabs Healthcare Xprezzon Bedside Monitor, Model 91393, is a component of the Spacelabs Healthcare Patient Monitoring System. The Xprezzon Bedside Monitor accepts inputs from the family of Spacelabs Parameter Modules. The monitor accept and displays parameter information, waveform and numeric data, and alarm conditions including arrhythmia information received from the same family of modules. (See table).
| Parameters | ModelNumber | Description / Comments | 510(k) |
|---|---|---|---|
| Anesthesia Gas• C02• 02• N20• Desflurane;• Enflurane;• Halothane;• Isoflurane;• Sevorflurane. | 91518 | Multigas Analyzer Module | K053599 |
| • Carbon dioxide• Oxygen | 91517 | Capnography Module | K031124 |
| • EGG• SpO2• NIBP (optional) | 90475 | Telemetry Receiver Module(Requires Transmitter Module) | K050605 |
| • EGG,• Respiration,• Invasive BloodPressure• Non-InvasiveBlood Pressure• SpO2,• Temperature,• Cardiac Output | 91496 | Ultraview SL™ CommandModule | K103142 |
| ECG | 90492 | 12-Lead EGG Module | K942058 |
| EEG, Dual Channel | 90480 | EEG Module | K932842 |
| EEG | 90481 | EEG Module | K932842 |
| EEG | 91482 | BISx Module | K060900 |
| Mixed venous oxygensaturation | 91424 | SVC/ScVO 2 Module | K893867 |
| Thermal printer | 90469 | 2/4 channel printer Module | K842616 |
| Thermal printer | 90449 | 2 channel printer Module | K842616 |
{2}------------------------------------------------
| Parameters | ModelNumber | Description / Comments | 510(k) |
|---|---|---|---|
| Interface to ExternalDevice | 90442-A | Flexport Interface Module;UNIVERSAL FLEXPORT | K903702 |
| 90421 | Flexport Interface Module,Compatible with:• NOVA515• NELLCOR• OHMEOA | ||
| 90433 | Flexport Interface Module,Compatible with:• NORMOCAP CD-02• NELLCOR,N-2500• DATEX CAPNO 11• DATEX PB254• 5200• N1260• DATEX PB254 | ||
| 90434 | Flexport Interface Module,Compatible with:• NOVAMETRIX 1000• NELLCOR N1000• CRITICARE POET | ||
| 90435 | Flexport Interface Module,Compatible with:• DINAMAP,8100,NIBP• DINAMAP NIBP | ||
| Parameters | ModelNumber | Description / Comments | 510(k) |
| Interface to ExternalDevice (Continued) | 90436 | Flexport Interface Module,Compatible with:• PB7200 W/ANALOG INTRFC• PB7200 W/ANALOG INTRFC• VELA, VIASYS VENT• DRAGER EVITA 4 VENT• PB840, VENTILATORINTERFACE• ET/AFLEXPORT,ENGSTROM• ERICANGSTROM ELVIRA• ENGSTROM ERICA/ELVIRA• BEAR 1000• DRAGER NARKOMED 2B,2C• DRAGER EVITA 2 & EVITA 2DURA• DRAGER VENT, INTRFC• OHMEDA 7800/10, INTRFC• HAMILTON VENT INTRFC• INFANISIAR INTRFC• ADULTSTAR• SIEMENS S300• SIEMENS S990• INFANT STAR INTFCRT• PB7200A/RESPIRONICS• ESPRIT• SIEMENS S990• PB7200A | K903702 |
| 90437 | Flexport Interface Module,Compatible with;• BRAUN BCC• BAXTER FLO-GARD• ABBOTT PLUM• IVAC INFUPIMP• IMED INFU PMP• ABBOTT INFU PIMP | ||
| 90438 | Flexport Interface Module,Compatible with:• NOVAMETRIX 840/860• TRANSCUTANEOUS ANAL | ||
| Parameters | ModelNumber | Description / Comments | 510(k) |
| 90439 | Flexport Interface Module,Compatible with:• PULSION P1000• PULSION• PICCO INTERFACE | ||
| 90443 | Flexport Interface Module,Compatible with:• DRAGER CICERO EM• DRAEGER CATO• OHMEDA RASCALI1• ENGSTROMEAS• DRAGER CICERO-B• DATEX ULTIMA W/ANALOG• OHMEDA, RGM• NARKOMED I• BICORE | ||
| 90444A | Flexport Interface Module,Compatible with:• INCUBATOR INTFC• OHMEDA | ||
| Interface to ExternalDevice (Continued) | 90451 | Flexport Interface Module,Compatible with:• Spacelabs FETALMONITORS | K903702 |
| 90519 | Flexport. Interface Module,Compatible with:• 90519B,BASE UNIT | ||
| 91436 | Flexport Interface Module,Compatible with:• RADIOMETER ,• GE CARESTATION, E• ENGSTROM,91436E• GE AVANCE• GE AVANCE,914360• VIASYS ,91436C• SERVO 1,91436B• PULMONETICS | ||
| 91438 | Flexport Interface Module,Compatible with:• RADIOMETER GE• ENGSTROM CS |
000029
29 September 2011
Page 3 of 7
Spacelabs Healthcare Special 510(k)
Xprezzon Monitor – 510(k) Summary
{3}------------------------------------------------
000030
29 September 2011 Page 4 of 7
·
Spacelabs Healthcare Special 510(k)
Xprezzon Monitor – 510(k) Summary
·
{4}------------------------------------------------
The Xprezzon Bedside monitor, model 91393, is configured at installation to operate independent of or connected to the Spacelabs Patient monitoring Network. As an independent bedside monitor the device operates from AC and. presents waveform, numeric data, and alarm conditions, including arrhythmia information, received from parameter modules. When physically networked these monitors are able to share their information with a central station or with other monitors on the network according to conditions
000031
Spacelabs Healthcare Special 510(k) Xprezzon Monitor - 510(k) Summary
29 September 2011 Page 5 of 7
{5}------------------------------------------------
Image /page/5/Picture/0 description: The image shows handwritten text. The top line reads "K112962". The second line reads "P6/7". The text appears to be written in black ink on a white background.
establish by the user/system administrator. They are also able to connect, via the healthcare institution's network, through Dynamic Network Access (DNA) to other applications available on the network.
Comparison to Predicate Device
The 91393 is substantially equivalent to their the Spacelabs Medical Ultraview SL Patient Monitors, model 91387. All devices offer the same parameter monitoring capabilities, dependant on the parameter modules employed. The model 91393 is only available as a bedside monitor and unlike the model 91387 may not be used as a central station.
The following changes were incorporated in the model 91393:
Change made to plastic material (remained PVC) giving the patient monitor a "new look". CPU boards and internal DC power supplies were also updated during this project, no functional change were made.
The maximum parameter capacities of the 91393 are the same as its predicate.
The number of internal module slots and the maximum number of remote module housings available for use with parameter modules have not changed for the 91393 from their predicate.
Display resolution has also been expanded on the 91387 and 91370 portable as technology became available. Where the 90364 was 768/1024, the 91387 resolution has been increased to 1024/768. All but one of the Spacelabs portable monitors remained identical to the predicate 90369 display resolution, with only the 91370 supporting a higher 1024/768 resolution.
The CPU PCI3A (670-1275-XX) maintenance release was implemented to improve production yield. Changes were also made as a result of employing digital signal integrity analysis tool, resulting improved signal integrity of the circuit board assembly.
The operating system was updated with the release of 2.03.OX software for the 91387, 91367, 91369 and 91370 monitors. This update, supplied by VxWorks, and adapted by Spacelabs Medical allowed for implementation of a higher level of security for the DNA and Wireless network for the monitors, as well as updating various drivers such as USB.
Intended use:
The Spacelabs Healthcare Xprezzon Bedside Monitor passively displays data generated by Spacelabs parameter modules, Flexport interfaces, and other Spacelabs SDLC based products as waveform and numeric displays, trends and alarms. Key monitored parameters available on the model 91393. when employing the Spacelabs Command Module, consist of ECG, respiration, invasive and noninvasive blood pressure, Sp02, temperature and cardiac output. Additional parameters and interfaces to other systems are also available depending on the parameter modules employed.
The Spacelabs Healthcare Xprezzon Bedside Monitor is intended to alert the user to alarm conditions that are reported by Spacelabs Healthcare parameter modules and/or other devices via Flexport interfaces. The Xprezzon Bedside Monitor is also capable of displaying alarm conditions on other monitors that are on the network through the Alarm Watch feature.
The Spacelabs Healthcare Xprezzon Bedside Monitor may also function as a generic display or computer terminal. As a generic display or terminal, the
Image /page/5/Picture/16 description: The image shows the text '000032 29 September 2011 Page 6 of 7'. The text is arranged in three lines, with '000032' on the left, '29 September 2011' on the top right, and 'Page 6 of 7' on the bottom right. The text is in a clear, legible font.
{6}------------------------------------------------
patient monitor allows network based applications to open windows and display information the Xprezzon and other networked monitors.
The Spacelabs Healthcare Xprezzon Bedside Monitor is designed to communicate with a variety of external devices such as displays, network devices, serial devices, user input devices, audio systems, and local/remote recorders.
The Xprezzon Bedside Monitor is intended for use under the direct supervision of a licensed healthcare practitioner, or by personnel trained in proper use of the equipment in a hospital environment.
Test Discussion:
The Spacelabs Healthcare Xprezzon Bedside Monitor, Model 91393, is substantially equivalent in design concepts, technologies and materials to the predicate cleared under K102422. The Xprezzon Bedside Monitor was validated through rigorous testing that, in part, support the compliance of the software to the Standards mentioned in the Software section of this submission. Additionally, the Xprezzon Bedside Monitor's software was developed following a robust software development process that was fully specified and validated. Test programs verified that parameter data provided by parameter modules, not part of this submission, to the Xprezzon Monitor could be accurately presented and that the interface supported the intended clinica! work flows and met the user's clinical needs.
predicate devices found substantially equivalent under K102422.
Test The Spacelabs Healthcare Xprezzon Bedside Monitor, Model 91393, is Conclusion: substantially equivalent to its predicate device in design concepts, technologies and materials. Testing demonstrates that Spacelabs Healthcare Xprezzon Bedside Monitor, Model 91393 is as safe and effective as the
000033
{7}------------------------------------------------
Image /page/7/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the circumference. Inside the circle is a stylized graphic of what appears to be an abstract caduceus symbol, featuring a series of curved lines that resemble a bird or a stylized human form.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
NOV - 2 2011
Spacelabs Medical, Inc. c/o Mr. David J. Geraghty Manager, Regulatory and Compliance 5150 220 th Ave SE Issaquah, WA 98029-6834
Re: K112962
Trade/Device Name: Spacelabs Healthcare Xprezzon Bedside Monitor Regulatory Number: 21 CFR 870.1025 Regulation Name: Patient Physiological Monitor (with arrhythmia detection or alarms) Regulatory Class: II (two) Product Code: 74 MHX Dated: October 3, 2011 Received: October 5, 2011
Dear Mr. Geraghty:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{8}------------------------------------------------
Page 2 - Mr. David J. Geraghty
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH0ffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Debra D. Zuckerman, M.D.
m D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{9}------------------------------------------------
Indications for Use Form
510(k) Number (if known): K112962
Device Name: Spacelabs Healthcare Xprezzon Bedside Monitor
Indications for Use:
The Spacelabs Healthcare Xprezzon Bedside Monitor passively displays data generated by Spacelabs parameter modules, Flexport interfaces, and other Spacelabs SDLC based products as waveform and numeric displays, trends and alarms. Key monitored parameters available on the model 91393, when employing the Spacelabs Command Module, consist of ECG, respiration, invasive and noninvasive blood pressure, Sp02, temperature and cardiac output. Additional parameters and interfaces to other systems are also available depending on the parameter modules employed.
The Spacelabs Healthcare Xprezzon Bedside Monitor is intended to alert the user to alarm conditions that are reported by Spacelabs Healthcare parameter modules and/or other devices via Flexport interfaces. The patient monitors are also capable of displaying alarm conditions on other monitors that are on the network through the Alarm Watch feature.
The Spacelabs Healthcare Xprezzon Bedside Monitor may also function as a generic display or computer terminal. As a generic display or terminal, the patient monitor allows network based applications to open windows and display information the Xprezzon and other networked monitors.
The Spacelabs Healthcare Xprezzon Bedside Monitor is designed to communicate with a variety of external devices such as displays, network devices, serial devices, user input devices, audio systems, and local/remote recorders.
The Xprezzon Bedside Monitors is intended.for use under the direct supervision of a licensed healthcare practitioner, or by personnel trained in proper use of the equipment in a hospital environment.
XX Prescription Use: (Part 21 CFR 801 Subpart D)
AND/OR
Over-Thé-Counter Use (21 CFR 801 Subpart C
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Division Sign-Off)
Page 1 of 1
000021
§ 870.1025 Arrhythmia detector and alarm (including ST-segment measurement and alarm).
(a)
Identification. The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.